Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
OncoSec Medical Incorporated
Feb 18, 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Jan 25, 2021
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
Jan 20, 2021
OncoSec Medical Announces Proposed Public Offering of Common Stock
Jan 19, 2021
OncoSec Enters into Option Agreement with Sirtex Medical to Co-Promote TAVO(TM)
Jan 08, 2021
OncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO(TM) Plus OPDIVO® as Neoadjuvant Therapy for Melanoma
Dec 10, 2020
OncoSec Strengthens IP Portfolio with Allowance of Two European Patent Applications Covering TAVO(TM) and Its Gene Electrotransfer Technology
Nov 24, 2020
OncoSec Announces Exclusive License Agreement for Cliniporator® Gene Electrotransfer Platform Developed by IGEA Clinical Biophysics
Nov 05, 2020
OncoSec Hosting an Investor and Analyst Day Webinar Showcasing Positive KEYNOTE-695 Data in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma
Nov 03, 2020
OncoSec to Present Positive Interim Data from KEYNOTE-695 Trial in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma at SITC 2020
Oct 29, 2020
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
Oct 12, 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Oct 06, 2020
OncoSec Announces Issuance of New U.S. Patent Expanding Coverage of TAVO(TM) and Its Gene Delivery Platform
Aug 27, 2020
OncoSec Announces Initiation of a Phase 2 Study at the Moffitt Cancer Center to Evaluate the Combination of TAVO plus OPDIVO® as Neoadjuvant Therapy for Melanoma
Aug 25, 2020
OncoSec to Present at the LD 500 Virtual Conference on September 2, 2020
Aug 16, 2020
OncoSec Medical Incorporated Announces Pricing of Public Offering
Aug 14, 2020
OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
Jul 27, 2020
OncoSec Appoints Kellie Malloy Foerter as Chief Operating Officer
Jul 13, 2020
OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program by NBC TV in Portland, Oregon
Jun 24, 2020
OncoSec Set to Join Russel Microcap® Index
Jun 22, 2020
OncoSec Presents Two Late-Breaking Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II
Page 1
››
Latest News
Apr 24, 2024
LCI Industries First-Quarter 2024 Conference Call Scheduled for May 8, 2024, at 8:30 a.m. ET
Apr 24, 2024
Sensata Technologies Board Approves Q2 Dividend of $0.12 Per Share
Apr 24, 2024
Masco Corporation Reports First Quarter 2024 Results
Apr 24, 2024
TotalEnergies and Vanguard Renewables, a Portfolio Company of BlackRock’s Diversified Infrastructure Business...
Apr 24, 2024
2024 Talent Experience Award Winners Celebrated at IAMPHENOM
Apr 24, 2024
Teledyne Technologies Reports First Quarter Results
Apr 24, 2024
Piedmont Lithium to Release First-Quarter 2024 Results on May 9, 2024
Apr 24, 2024
Avery Dennison Announces First Quarter 2024 Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events